Stay updated on Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest expected in July 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.4.SummaryDifference0.7%
- Check53 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check69 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and has removed extensive details about a long-term study on nemolizumab for moderate-to-severe atopic dermatitis.SummaryDifference6%
- Check158 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check167 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check188 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.